Dr. Gary E. Goodman
Claim this profileProvidence Portland Medical Center
Studies Breast Cancer
Studies Lung Cancer
17 reported clinical trials
40 drugs studied
About Gary E. Goodman
Education:
- Obtained an MD from the University of California, San Francisco, School of Medicine in 1986.
- Completed a Residency in Internal Medicine at Oregon Health & Science University (1986-1989).
- Undertook a Fellowship in Hematology/Oncology at Oregon Health & Science University (1989-1992).
Experience:
- Currently practices as a hematologist and oncologist at Providence Portland Medical Center.
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
Stage I
2Lung Cancer
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Gary E. Goodman is currently running
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Encorafenib/Binimetinib/Nivolumab vs Ipilimumab/Nivolumab
for Melanoma
This phase II trial compares the effect of encorafenib, binimetinib, and nivolumab versus ipilimumab and nivolumab in treating patients with BRAF- V600 mutant melanoma that has spread to the brain (brain metastases). Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Ipilimumab and nivolumab are monoclonal antibodies that may interfere with the ability of tumor cells to grow and spread. This trial aims to find out which approach is more effective in shrinking and controlling brain metastases from melanoma.
Recruiting1 award Phase 223 criteria
More about Gary E. Goodman
Clinical Trial Related6 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Gary E. Goodman has experience with
- Ramucirumab
- Paclitaxel
- Irinotecan Hydrochloride
- Gemcitabine Hydrochloride
- Lenalidomide
- Daratumumab/rHuPH20
Breakdown of trials Gary E. Goodman has run
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gary E. Goodman specialize in?
Gary E. Goodman focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Gary E. Goodman currently recruiting for clinical trials?
Yes, Gary E. Goodman is currently recruiting for 5 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Gary E. Goodman has studied deeply?
Yes, Gary E. Goodman has studied treatments such as Ramucirumab, Paclitaxel, Irinotecan Hydrochloride.
What is the best way to schedule an appointment with Gary E. Goodman?
Apply for one of the trials that Gary E. Goodman is conducting.
What is the office address of Gary E. Goodman?
The office of Gary E. Goodman is located at: Providence Portland Medical Center, Portland, Oregon 97213 United States. This is the address for their practice at the Providence Portland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.